Drug delivery system for melanoma therapy may target the several pathways involved in melanoma development such as three-tiered Ras/Raf/MEK mitogen-activated protein kinase (MAPK); PI(3)K; NF-kappaB; p16INK4a/RB and ARF signalling pathways. This evidence concerns the gene MAP2K7 and melanoma.